Transforming medicine

Proposed Capital Raising

Acacia Pharma Group plc - Results of Placing - EUR 27 million Raised to Invest Further in US Launch and Commercialization Activities

Acacia Pharma Group plc - Proposed Capital Raising by way of a Placing of New Ordinary Shares and Update on Early Positive Market Reception to US Launch of BARHEMSYS®

Issues of New Ordinary Shares in Connection with the Byfavo™ Acquisition

Proposed Capital Raising

Acacia Pharma Prospectus: Issue of 12,500,000 New Ordinary Shares

Acacia Pharma Group plc - Proposed Capital Raising by way of a Placing of New Ordinary Shares

Issues of New Ordinary Shares in Connection with the BYFAVO™ Acquisition

Acacia Pharma Prospectus: Issues of New Ordinary Shares in connection with the BYFAVO™ Acquisition